XML 33 R25.htm IDEA: XBRL DOCUMENT
v3.25.2

Revenue (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Revenue from Contract with Customer [Abstract] |
Schedule of Disaggregated Revenue | The following table presents our disaggregated revenue for the periods presented (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
MRD revenue |  |  |  |  |  |  |  |  |  |  |  |
Service revenue |  | $ | 44,438 |  |  | $ | 32,284 |  |  | $ | 83,659 |  |  | $ | 60,410 |
Regulatory milestone revenue |  |  | 5,500 |  |  |  | 3,000 |  |  |  | 10,000 |  |  |  | 7,500 |
Total MRD revenue |  |  | 49,938 |  |  |  | 35,284 |  |  |  | 93,659 |  |  |  | 67,910 |
Immune Medicine revenue |  |  |  |  |  |  |  |  |  |  |  |
Service revenue |  |  | 5,001 |  |  |  | 6,148 |  |  |  | 10,123 |  |  |  | 10,707 |
Collaboration revenue |  |  | 3,940 |  |  |  | 1,758 |  |  |  | 7,540 |  |  |  | 6,446 |
Total Immune Medicine revenue |  |  | 8,941 |  |  |  | 7,906 |  |  |  | 17,663 |  |  |  | 17,153 |
Total revenue |  | $ | 58,879 |  |  | $ | 43,190 |  |  | $ | 111,322 |  |  | $ | 85,063 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration